跳至主要内容
临床试验/EUCTR2022-002352-39-FR
EUCTR2022-002352-39-FR进行中(未招募)1 期

Follow-up of Contact Persons at Risk of Monkeypox infection: prospective cohort study (MONKEY VAX) - MONKEY VAX

Assistance Publique – Hôpitaux de Paris (AP-HP)0 个研究点目标入组 226 人开始时间: 2022年6月20日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
226

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age = 18 years old
  • - Be a contact person at risk of exposure to the Monkeypox virus as validated by Public Health France (SPF) for less than 14 days following the last contact with the case and not vaccinated
  • Be a contact person at risk of exposure to the Monkeypox virus as validated by SPF and having received a first post-exposure injection less than 28 days ago
  • - Signature of informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 26

排除标准

  • - Being under guardianship or curatorship
  • - No coverage by social security
  • - Subject subject to a legal protection measure
  • - Have a contraindication to Monkeypox vaccination
  • - Present a known or suspected allergy to one of the components of the vaccine
  • - Diagnosis of Monkeypox

研究者

发起方
Assistance Publique – Hôpitaux de Paris (AP-HP)

相似试验